跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,940 条关于
“PL BioScience GmbH”
全部
2,940
临床试验
147
药物
638
机构
1,016
资讯
1,139
7个月前
PL BioScience Secures Japan PMDA Certification for Cell Culture Media, Advancing Regenerative Medicine Development
去年
PL BioScience Develops World's First Artificial Human Platelet Lysate for Cell Culture Applications
去年
Polyrizon Advances PL-14 Allergy Blocker with Successful Safety Study and Clinical Strategy
去年
PL Developments Receives FDA Approval for Omeprazole OTC
去年
Polyrizon Secures Manufacturing Agreement with Eurofins CDMO for PL-14 Allergy Blocker
去年
TQ Therapeutics Acquires Juno GmbH to Advance Decentralized Cell Therapy Platform
6个月前
AveThera GmbH Acquires Fraunhofer ITEM Braunschweig Site to Expand Biopharmaceutical Manufacturing
去年
PL Developments Gains FDA Approval for Omeprazole OTC and Completes Debt Refinancing
9个月前
Polyrizon Submits FDA Pre-Request for PL-16 Viral Blocker with Over 90% Efficacy Against Respiratory Viruses
去年
PL Developments Receives FDA Approval for Over-the-Counter Omeprazole
第 1 页,共 114 页
上一页
下一页